Literature DB >> 12874096

Role of reactive oxygen species in endothelin-induced hypertension.

Mona H Sedeek1, Maria T Llinas, Heather Drummond, Lourdes Fortepiani, Sean R Abram, Barbara T Alexander, Jane F Reckelhoff, Joey P Granger.   

Abstract

Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1-treated rats was 141+/-3 mm Hg, compared with 125+/-2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3+/-2.5 versus 10+/-1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5+/-0.9 versus 8.7+/-0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2alpha excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127+/-4 versus 127+/-4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2alpha in the endothelin-1-treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874096     DOI: 10.1161/01.HYP.0000084372.91932.BA

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

1.  CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia.

Authors:  Kedra Wallace; Denise C Cornelius; Jeremy Scott; Judith Heath; Janae Moseley; Krystal Chatman; Babbette LaMarca
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

2.  Contribution of Ras farnesyl transferase, MAP kinase and cytochrome P-450 metabolites to endothelin-1 induced hypertension.

Authors:  Farid Ljuca; Gorazd Drevenšek; Enver Zerem
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

3.  Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.

Authors:  Babbette LaMarca; Kedra Wallace; Florian Herse; Gerd Wallukat; James N Martin; Abram Weimer; Ralf Dechend
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  Reactive oxygen species contribute to sleep apnea-induced hypertension in rats.

Authors:  Carmen M Troncoso Brindeiro; Ana Q da Silva; Kyan J Allahdadi; Victoria Youngblood; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-31       Impact factor: 4.733

Review 5.  Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease.

Authors:  Victoria M Pak; Michael A Grandner; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-04-22       Impact factor: 11.609

6.  Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.

Authors:  Mona Sedeek; Jeffrey S Gilbert; Babbette B LaMarca; Myssara Sholook; Derrick L Chandler; Yuping Wang; Joey P Granger
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

7.  Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV.

Authors:  Dan Wang; Joseph K Melancon; Jennifer Verbesey; Haihong Hu; Chenglong Liu; Shakil Aslam; Mary Young; Christopher S Wilcox
Journal:  J AIDS Clin Res       Date:  2013-12-01

8.  Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  Hypertension       Date:  2013-01-14       Impact factor: 10.190

9.  Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.

Authors:  Babbette Lamarca; Joshua Speed; Lillian Fournier Ray; Kathy Cockrell; Gerd Wallukat; Ralf Dechend; Joey Granger
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-11

10.  The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Authors:  Roxanna A Irani; Yujin Zhang; Sean C Blackwell; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.